Venturi Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Venturi Wealth Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-16	Closed	-$1.32K	–	1487
2024 Q4	$1.32K	Hold	16	–	–	﹤0.01%	1889
2024 Q3	$1.39K	Buy	+16	New	+$1.37K	﹤0.01%	1727

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

MWM

MGB Wealth Management Addison, Texas $350M AUM 42.75% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

DBIA

Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return

Venturi Wealth Management's PJP Position: Q1 2025 in Review

Venturi Wealth Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2025, closing a stake of 16 shares — an estimated $1.32K sold.

Venturi Wealth Management first reported a position in PJP in Q3 2024 and held it in 2 quarters. The position peaked at $1.39K in Q3 2024. 96 funds tracked by Wall St. Rank hold PJP as of Q1 2025.

Venturi Wealth Management reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2025 after selling out during the quarter.
Venturi Wealth Management sold 16 Invesco Pharmaceuticals ETF shares in Q1 2025, an estimated $1.32K.
Venturi Wealth Management first reported a position in Invesco Pharmaceuticals ETF in Q3 2024 and held it in 2 quarters.
Venturi Wealth Management's Invesco Pharmaceuticals ETF position peaked at $1.39K in Q3 2024.
96 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2025.

Based on Venturi Wealth Management's 13F filing for Q1 2025, filed 6 May 2025.